XML 17 R7.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Deficit [Member]
Beginning Balance at Jun. 30, 2019 $ 222,829 $ 50 $ 289,768 $ (366) $ (66,623)
Beginning Balance, Shares at Jun. 30, 2019   50,518,460      
Issuance of common stock upon exercise of stock options 3,805 $ 1 3,804 0 0
Issuance of common stock upon exercise of stock options, Shares   667,651      
Release of restricted stock, net of share settlement 0 $ 1 (1) 0 0
Release of restricted stock, net of share settlement, Shares   751,963      
Stock-based compensation expense 11,269 $ 0 11,269 0 0
Withholding taxes related to release of restricted stock, net of share settlement (5,413) 0 (5,413) 0 0
Net income 16,600 0 0 0 16,600
Other comprehensive income (loss) 117 0 0 117 0
Ending Balance at Mar. 31, 2020 249,207 $ 52 299,427 (249) (50,023)
Ending Balance, Shares at Mar. 31, 2020   51,938,074      
Beginning Balance at Dec. 31, 2019 233,871 $ 52 298,080 (319) (63,942)
Beginning Balance, Shares at Dec. 31, 2019   51,636,757      
Issuance of common stock upon exercise of stock options 689 $ 0 689 0 0
Issuance of common stock upon exercise of stock options, Shares   151,625      
Release of restricted stock, net of share settlement 0 $ 0 0 0 0
Release of restricted stock, net of share settlement, Shares   149,692      
Stock-based compensation expense 1,884 $ 0 1,884 0 0
Withholding taxes related to release of restricted stock, net of share settlement (1,226) 0 (1,226) 0 0
Net income 13,919 0 0 0 13,919
Other comprehensive income (loss) 70 0 0 70 0
Ending Balance at Mar. 31, 2020 249,207 $ 52 299,427 (249) (50,023)
Ending Balance, Shares at Mar. 31, 2020   51,938,074      
Beginning Balance at Jun. 30, 2020 $ 255,944 $ 52 304,650 (237) (48,521)
Beginning Balance, Shares at Jun. 30, 2020 52,209,813 52,209,813      
Issuance of common stock upon exercise of stock options $ 3,764 $ 1 3,763 0 0
Issuance of common stock upon exercise of stock options, Shares   699,100      
Release of restricted stock, net of share settlement 0 $ 1 (1) 0 0
Release of restricted stock, net of share settlement, Shares   703,386      
Stock-based compensation expense 15,238 $ 0 15,238 0 0
Withholding taxes related to release of restricted stock, net of share settlement (6,518) 0 (6,518) 0 0
Net income 20,184 0 0 0 20,184
Other comprehensive income (loss) (45) 0 0 (45) 0
Ending Balance at Mar. 31, 2021 $ 288,567 $ 54 317,132 (282) (28,337)
Ending Balance, Shares at Mar. 31, 2021 53,612,299 53,612,299      
Beginning Balance at Dec. 31, 2020 $ 279,406 $ 53 313,017 (290) (33,374)
Beginning Balance, Shares at Dec. 31, 2020   53,259,519      
Issuance of common stock upon exercise of stock options 1,184 $ 1 1,183 0 0
Issuance of common stock upon exercise of stock options, Shares   214,075      
Release of restricted stock, net of share settlement 0 $ 0 0 0 0
Release of restricted stock, net of share settlement, Shares   138,705      
Stock-based compensation expense 4,870 $ 0 4,870 0 0
Withholding taxes related to release of restricted stock, net of share settlement (1,938) 0 (1,938) 0 0
Net income 5,037 0 0 0 5,037
Other comprehensive income (loss) 8 0 0 8 0
Ending Balance at Mar. 31, 2021 $ 288,567 $ 54 $ 317,132 $ (282) $ (28,337)
Ending Balance, Shares at Mar. 31, 2021 53,612,299 53,612,299